Valemetostat Tosylate
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Valemetostat Tosylate, covering 2024-07-22 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma [Phase 2]